Free Trial

Core FI's softer impetus stemming......>

BOND SUMMARY
BOND SUMMARY: Core FI's softer impetus stemming from the (caveated) positive
initial Moderna vaccine trial faded as we moved through Asia-Pac trade, with a
focus on the bubbling Sino-U.S. tensions after U.S. President Trump formally
signed the Hong Kong Bill into law. T-Notes last -0-03+ at 139-10, with yields
unchanged to 0.9bp cheaper across the curve.
- JGB futures showed lower, but edged away from worst levels, holding a tight
range. Contract last -4. The curve twist steepened with the super-long end
cheapening. The BoJ decision offered up no surprises, while Tokyo has lifted the
level of its COVID-19 warning to the highest possible.
- Aussie bond futures saw a flattening impetus in play in Sydney trade, with an
eye on the pullback in mainland China equities and the local COVID-19 situation
in Australia. A reminder that the latest round of Westpac monthly consumer
confidence data reflected worry surrounding the COVID-19 situation. YM +0.5, XM
+2.5.
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.